Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.

Thrombosis and haemostasis - 1 Oct 2004

Schneider Beate, Becker Maria, Brackmann Hans-Hermann, Eis-Hübinger Anna Maria

Abstract excerpt

Human parvovirus B19 (B19) DNA has frequently been detected in plasma-derived coagulation factor concentrates. Furthermore, transmission of B19 infection was observed, indicating presence of the infectious virus despite routine viral inactivation/removal procedures during the manufacturing process. Recently, human parvovirus DNA isolates, variant from B19, have been identified resulting in classification of B19...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation Factors
Share to DNA, Viral
Share to Drug Contamination

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Parvoviridae Infections

Share to Parvovirus B19, Human

Share to Polymerase Chain Reaction

Share to Quality Control

Source

Identifiers

PMID: 15467916
DOI: 10.1160/TH04-04-0229

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.PMID 15467916Read ↗

Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testingSemantic proximity Read ↗

Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.Semantic proximity Read ↗

Human parvovirus PARV4 in clotting factor VIII concentratesSemantic proximity Read ↗

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentratesSemantic proximity Read ↗

Parvovirus B19 transmission by heat‐treated clotting factor concentratesSemantic proximity Read ↗

Parvovirus B19V DNA contamination in Chinese plasma and plasma derivativesSemantic proximity Read ↗

Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.Semantic proximity Read ↗

Parvovirus B19 transmission by a high‐purity factor VIII concentrateSemantic proximity Read ↗

Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.Semantic proximity Read ↗

A serious parvovirus B19 genotype 2 infection not detected in a commercial PCR assay.Semantic proximity Read ↗

Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation sensitivity by liquid-heating.Semantic proximity Read ↗

Inactivation and neutralization of parvovirus B19 Genotype 3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.